$33.72
-0.78-2.26%
At Close: -
$33.72
00.00%
After Hours: Jul 5, 4:00 PM EDT
15 minutes delayed
Protagonist Therapeutics
PTGXNASDAQ
Protagonist Therapeutics (PTGX) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestOverview Rating
Promising
want to know what
the Bulls & Bears Say?
Protagonist Therapeutics (NASDAQ:PTGX) Stock Quotes, Forecast and News Summary
Protagonist Therapeutics Stock (NASDAQ: PTGX) stock price, news, charts, stock research, profile.
| Open | $34.14 |
| Close | $33.72 |
| Volume / Avg. | 777.83K / 861.65K |
| Day Range | 33.21 - 34.57 |
| 52 Wk Range | 13.72 - 35.96 |
| Market Cap | $1.98B |
| P/E Ratio | 13.58 |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 57 |
| Short Interest | 5.39% |
| Days to Cover | 4.15 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Protagonist Therapeutics Inc
Sector
Health Care
Industry
Biotechnology
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary tech...
Show More
Compare
EPS better than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS better than industry
FAQ
How do I buy Protagonist Therapeutics (PTGX) stock?
You can purchase shares of Protagonist Therapeutics (NASDAQ:PTGX) through any online brokerage.
Who are Protagonist Therapeutics (PTGX) competitors?
Other companies in Protagonist Therapeutics’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), Syndax Pharmaceuticals (NASDAQ:SNDX), PTC Therapeutics (NASDAQ:PTCT), Agios Pharmaceuticals (NASDAQ:AGIO) and Apogee Therapeutics (NASDAQ:APGE).
What is the target price for Protagonist Therapeutics (PTGX) stock?
There is no analysis for Protagonist Therapeutics.
What is the forecast for Protagonist Therapeutics (PTGX) stock?
Protagonist Therapeutics has a consensus price target of $40.55.
Current stock price for Protagonist Therapeutics (PTGX)?
The stock price for Protagonist Therapeutics (NASDAQ: PTGX) is $33.72 last updated July 5, 2024 at 4:00 PM EDT.
Does Protagonist Therapeutics (PTGX) pay a dividend?
There are no upcoming dividends for Protagonist Therapeutics.
When is Protagonist Therapeutics (NASDAQ:PTGX) reporting earnings?
Protagonist Therapeutics’s Q2 earnings are confirmed for Thursday, August 1, 2024.
Is Protagonist Therapeutics (PTGX) going to split?
There is no upcoming split for Protagonist Therapeutics.
What sector and industry does Protagonist Therapeutics (PTGX) operate in?
Protagonist Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.